Medtronic (NYSE:MDT) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $88.67, a high estimate of $105.00, and a low estimate of $76.00. A 1.61% drop is evident in the current average compared to the previous average price target of $90.12. Decoding Analyst Ratings: A …